These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 18480207)

  • 41. Natriuretic peptides and the heart: current and future implications for clinical biochemistry.
    Penney MD
    Ann Clin Biochem; 2005 Nov; 42(Pt 6):432-40. PubMed ID: 16259793
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impaired renal function in patients with ischemic and nonischemic chronic heart failure: association with neurohormonal activation and survival.
    Smilde TD; Hillege HL; Navis G; Boomsma F; de Zeeuw D; van Veldhuisen DJ
    Am Heart J; 2004 Jul; 148(1):165-72. PubMed ID: 15215807
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The prognostic value of anemia, right-heart catheterization and neurohormones in chronic heart failure.
    Gardner RS; McDonagh TA
    Expert Rev Cardiovasc Ther; 2006 Jan; 4(1):51-7. PubMed ID: 16375628
    [TBL] [Abstract][Full Text] [Related]  

  • 44. B-type natriuretic peptide: time to incorporate natriuretic peptides in our practice.
    Daniels LB; Maisel A
    J Cardiovasc Med (Hagerstown); 2006 Jun; 7(6):414-5. PubMed ID: 16721203
    [No Abstract]   [Full Text] [Related]  

  • 45. Circulating natriuretic peptide levels in acute heart failure.
    Maisel A
    Rev Cardiovasc Med; 2007; 8 Suppl 5():S13-21. PubMed ID: 18192949
    [TBL] [Abstract][Full Text] [Related]  

  • 46. B-type natriuretic peptide in heart failure.
    Moe GW
    Curr Opin Cardiol; 2006 May; 21(3):208-14. PubMed ID: 16601459
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biomarkers in cardiovascular disease: beyond natriuretic peptides.
    Boswood A
    J Vet Cardiol; 2009 May; 11 Suppl 1():S23-32. PubMed ID: 19395333
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum cortisol as a useful predictor of cardiac events in patients with chronic heart failure: the impact of oxidative stress.
    Yamaji M; Tsutamoto T; Kawahara C; Nishiyama K; Yamamoto T; Fujii M; Horie M
    Circ Heart Fail; 2009 Nov; 2(6):608-15. PubMed ID: 19919986
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Natriuretic peptides and other biomarkers in chronic heart failure: from BNP, NT-proBNP, and MR-proANP to routine biochemical markers.
    Lainscak M; von Haehling S; Anker SD
    Int J Cardiol; 2009 Mar; 132(3):303-11. PubMed ID: 19144431
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Discovery and significance of natriuretic peptides].
    Nakao K; Tamura N
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():5-9. PubMed ID: 15506327
    [No Abstract]   [Full Text] [Related]  

  • 51. Natriuretic peptides in screening for cardiac dysfunction.
    Tang WH
    Heart Fail Clin; 2006 Jul; 2(3):323-32. PubMed ID: 17386901
    [No Abstract]   [Full Text] [Related]  

  • 52. Selenium contributes to myocardial injury and cardiac remodeling in heart failure.
    Alexanian I; Parissis J; Farmakis D; Pantziou C; Ikonomidis I; Paraskevaidis I; Ioannidou S; Sideris A; Kremastinos D; Lekakis J; Filippatos G
    Int J Cardiol; 2014 Sep; 176(1):272-3. PubMed ID: 25042657
    [No Abstract]   [Full Text] [Related]  

  • 53. [Natriuretic peptides and valvular heart disease].
    Yasumura Y
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():93-4. PubMed ID: 15506345
    [No Abstract]   [Full Text] [Related]  

  • 54. Biomarkers in heart failure.
    Eleuteri E; Di Stefano A
    Minerva Cardioangiol; 2012 Apr; 60(2):213-26. PubMed ID: 22495170
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Measuring myocyte oxidative stress and targeting cytokines to evaluate inflammatory response and cardiac repair after myocardial infarction.
    Fineschi V
    Curr Vasc Pharmacol; 2015; 13(1):3-5. PubMed ID: 25751417
    [No Abstract]   [Full Text] [Related]  

  • 56. Natriuretic peptides revisited: new potentials and challenges in heart failure.
    Farmakis D; Parissis J; Papingiotis G; Lekakis J; Filippatos G
    J Cardiovasc Med (Hagerstown); 2016 Nov; 17(11):840-2. PubMed ID: 27680306
    [No Abstract]   [Full Text] [Related]  

  • 57. [Molecular mechanisms of chronic heart failure].
    Kinugawa S; Tsutsui H
    Nihon Rinsho; 2007 Apr; 65 Suppl 4():87-91. PubMed ID: 17511070
    [No Abstract]   [Full Text] [Related]  

  • 58. Biomarkers in heart failure.
    Takeishi Y
    Int Heart J; 2014; 55(6):474-81. PubMed ID: 25341366
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biomarkers in acute heart failure syndromes - are they fulfilling their promise?
    Shah AN; Nodari S; Gheorghiade M
    Cardiology; 2011; 120(1):19-21. PubMed ID: 22085897
    [No Abstract]   [Full Text] [Related]  

  • 60. Natriuretic Peptides: Consensus Call for Use.
    Pascual Figal DA; Casademont J; Lobos JM; Piñera P; Bayes-Genis A; Ordóñez Llanos J; González-Juanatey JR
    Rev Esp Cardiol (Engl Ed); 2016 Sep; 69(9):817-9. PubMed ID: 27236277
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.